Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma.
暂无分享，去创建一个
Tuan S. Nguyen | N. Schmitz | Sonali M. Smith | K. Savage | T. Habermann | A. Mackensen | M. Ogura | K. Tobinai | M. Crump | S. Leppä | L. Fayad | E. Hsi | R. Rifkin | H. Hagberg | F. Offner | Je Jung Lee | A. Di Rocco | S. Yeh | L. Pinter-Brown | B. Lin | B. Kahl | D. Thornton | Peipei Shi | F. Schnell | M. Hahka‐Kemppinen